Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer. - Roudko V; Del Valle DM; Radkevich E; Kelly G; Hui X; Patel M; Gonzalez-Kozlova E; Tuballes K; Streicher H; Atale S; Wang L; CzinCzin B; et al. (Journal for immunotherapy of cancer, 2025)